Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Yeon Cheong

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
BMC Genetics|February 21, 2004
Linkage analysis of longitudinal dataYoung Ju Suh, Taesung Park, Soo Yeon Cheong
Annals of the Rheumatic Diseases|August 10, 2016
Difference between SB4 and reference etanercept in the hepatobiliary disorders not considered to be caused by SB4: response to letter by Scheinberg and AzevedoPaul Emery, Jiří Vencovský, Jeehoon Ghil, et al.
Journal of Visualized Experiments : Jove|September 17, 2014
Collection and extraction of saliva DNA for next generation sequencingMichael R Goode, Soo Yeon Cheong, Ning Li, et al.
Bioinformatics (Oxford, England)|October 2, 2008
Smarter clustering methods for SNP genotype callingYan Lin, George C Tseng, Soo Yeon Cheong, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 21, 2010
Pooling-based genome-wide association study implicates gamma-glutamyltransferase 1 (GGT1) gene in pancreatic carcinogenesisBrenda Diergaarde, Randall Brand, Janette Lamb, et al.
Annals of the Rheumatic Diseases|August 11, 2017
Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4Paul Emery, Jiří Vencovský, Anna Sylwestrzak, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 27, 2017
Phase III Randomized Study of SB5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate-to-Severe Rheumatoid ArthritisMichael E Weinblatt, Asta Baranauskaite, Jaroslaw Niebrzydowski, et al.
The American Journal of Psychiatry|October 31, 2013
A genome scan for loci shared by autism spectrum disorder and language impairmentChristopher W Bartlett, Liping Hou, Judy F Flax, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2025
Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studiesSonja Ständer, Sarina B Elmariah, Shawn G Kwatra, et al.
Rheumatology (Oxford, England)|October 3, 2017
52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritisPaul Emery, Jirí Vencovský, Anna Sylwestrzak, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
BMC Genetics|February 21, 2004
Linkage analysis of longitudinal dataYoung Ju Suh, Taesung Park, Soo Yeon Cheong
Annals of the Rheumatic Diseases|August 10, 2016
Difference between SB4 and reference etanercept in the hepatobiliary disorders not considered to be caused by SB4: response to letter by Scheinberg and AzevedoPaul Emery, Jiří Vencovský, Jeehoon Ghil, et al.
Journal of Visualized Experiments : Jove|September 17, 2014
Collection and extraction of saliva DNA for next generation sequencingMichael R Goode, Soo Yeon Cheong, Ning Li, et al.
Bioinformatics (Oxford, England)|October 2, 2008
Smarter clustering methods for SNP genotype callingYan Lin, George C Tseng, Soo Yeon Cheong, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 21, 2010
Pooling-based genome-wide association study implicates gamma-glutamyltransferase 1 (GGT1) gene in pancreatic carcinogenesisBrenda Diergaarde, Randall Brand, Janette Lamb, et al.
Annals of the Rheumatic Diseases|August 11, 2017
Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4Paul Emery, Jiří Vencovský, Anna Sylwestrzak, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 27, 2017
Phase III Randomized Study of SB5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate-to-Severe Rheumatoid ArthritisMichael E Weinblatt, Asta Baranauskaite, Jaroslaw Niebrzydowski, et al.
The American Journal of Psychiatry|October 31, 2013
A genome scan for loci shared by autism spectrum disorder and language impairmentChristopher W Bartlett, Liping Hou, Judy F Flax, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2025
Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studiesSonja Ständer, Sarina B Elmariah, Shawn G Kwatra, et al.
Rheumatology (Oxford, England)|October 3, 2017
52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritisPaul Emery, Jirí Vencovský, Anna Sylwestrzak, et al.
Pageof 2